Photo taken from LUNGevity Foundation/X
Jun 1, 2024, 21:10
LUNGevity Foundation – Subcutan injection or IV infusion for EGFR + NSCLC
LUNGevity Foundation shared a post on X:
“Subcutan injection or IV infusion? Does it matter? Phas 3 PALOMA-3 says it might. Researchers studied ami + oral laz in patients with adv EGFR + NSCLC for drug effic and safety. Manual subcutan injections had better PFS, DoR and pat convenience.”
Source: LUNGevity Foundation/X
